Literature DB >> 8205005

Genotype-phenotype correlations in beta-thalassemias.

A Cao1, R Galanello, M C Rosatelli.   

Abstract

In this paper we review the molecular basis of the marked heterogeneity of the thalassemia syndromes as well as the relative implications for carrier screening and prenatal diagnosis. The classical phenotype of heterozygous beta-thalassemia may be modified by a number of environmental and genetic interacting factors--among which the most relevant are: (1) coinheritance of alpha-thalassemia, which may normalize the red blood cell indices; (2) the presence of a mild beta-thalassemia mutation; (3) cotransmission of delta-thalassemia which may reduce the increase of HbA2 typical of heterozygous beta-thalassemia to normal values and (4) the presence of a silent mutation which can be defined only by imbalanced beta-globin chain synthesis. A number of molecular mechanisms are able to produce the non transfusion dependent attenuated forms of thalassemia syndromes referred to as thalassemia intermedia. The most common are homozygosity for mild beta-thalassemia mutations, coinheritance with homozygous beta-thalassemia of alpha-thalassemia or genetic determinants able to sustain a continuous production of HbF in adult life or the presence of heterozygosity for hyperunstable globin variants.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8205005     DOI: 10.1016/0268-960x(94)90002-7

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  10 in total

1.  Beta-thalassemia: from genotype to phenotype.

Authors:  Fabrice Danjou; Franco Anni; Renzo Galanello
Journal:  Haematologica       Date:  2011-11       Impact factor: 9.941

2.  Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion.

Authors:  Fabrice Danjou; Franco Anni; Lucia Perseu; Stefania Satta; Carlo Dessì; Maria Eliana Lai; Paolo Fortina; Marcella Devoto; Renzo Galanello
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

3.  Phenotypic heterogeneity of asian Indian inversion deletions gγ(aγδβ)0 breakpoint a and breakpoint B.

Authors:  Sanjay Pandey; Sweta Pandey; Ravi Ranjan; Rahasyamani Mishra; Monica Sharma; Renu Saxena
Journal:  Indian J Clin Biochem       Date:  2012-06-15

4.  Does size matter? Two new deletions in the HBB gene cause β0-thalassemia.

Authors:  Paloma Ropero; Fernando Ataúlfo González Fernández; Jorge M Nieto; Valle Recasens; Ángeles Montañés; María José Murúzabal; María Sarasa; Cristina Fernández; Ana Villegas; Cuesta C Benavente
Journal:  Ann Hematol       Date:  2022-04-25       Impact factor: 3.673

5.  Amelioration of Sardinian beta0 thalassemia by genetic modifiers.

Authors:  Renzo Galanello; Serena Sanna; Lucia Perseu; Maria Carla Sollaino; Stefania Satta; Maria Eliana Lai; Susanna Barella; Manuela Uda; Gianluca Usala; Goncalo R Abecasis; Antonio Cao
Journal:  Blood       Date:  2009-08-20       Impact factor: 22.113

6.  Pathophysiology and Clinical Manifestations of the β-Thalassemias.

Authors:  Arthur W Nienhuis; David G Nathan
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

7.  Genotype-phenotype correlation of β-thalassemia spectrum of mutations in an Indian population.

Authors:  Praveen Kishore Sahu; Sudhanshu Shekhar Pati; Saroj Kanti Mishra
Journal:  Hematol Rep       Date:  2012-06-26

8.  Recent advances in β-thalassemias.

Authors:  Antonio Cao; Paolo Moi; Renzo Galanello
Journal:  Pediatr Rep       Date:  2011-06-16

9.  Can homeopathy bring additional benefits to thalassemic patients on hydroxyurea therapy? Encouraging results of a preliminary study.

Authors:  Antara Banerjee; Sudipa Basu Chakrabarty; Susanta Roy Karmakar; Amit Chakrabarty; Surjyo Jyoti Biswas; Saiful Haque; Debarsi Das; Saili Paul; Biswapati Mandal; Boujedaini Naoual; Philippe Belon; Anisur Rahman Khuda-Bukhsh
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-29       Impact factor: 2.629

10.  Association of BCL11A genetic variant (rs11886868) with severity in β-thalassaemia major & sickle cell anaemia.

Authors:  Sneha Dadheech; D Madhulatha; Suman Jainc; James Joseph; A Jyothy; Anjana Munshi
Journal:  Indian J Med Res       Date:  2016-04       Impact factor: 2.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.